Manages pain severe enough to require an opioid analgesic. ANDA 76855, held by Specgx LLC. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 76855 (Hydromorphone Hydrochloride), held by Specgx LLC, was first approved by FDA on Dec 23, 2004, with 10 approved supplements and 0 published complete response letters.
Hydromorphone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including hydromorphone hydrochloride tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 23, 2004 | Original application | Approved |
| Hydromorphone Hydrochloride8MG · tablet;oral | Hydromorphone Hydrochloride | Rx |
| Hydromorphone Hydrochloride2MG · tablet;oral | Hydromorphone Hydrochloride | Rx |
| Hydromorphone Hydrochloride4MG · tablet;oral | Hydromorphone Hydrochloride | Rx |
| Jun 18, 2026 | Supplement 25REMS | Approved | None posted |
| Mar 13, 2025 | Supplement 19Labeling · Standard review | Approved | None posted |
| Mar 13, 2025 | Supplement 23Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 22REMS | Approved | None posted |
| Mar 9, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 9, 2020 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 9, 2020 | Supplement 17Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 13REMS | Approved | None posted |
| Feb 6, 2008 | Supplement 5Labeling | Approved | None posted |
| Nov 9, 2006 | Supplement 4Labeling | Approved | None posted |
| Dec 23, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters